A novel <it>Plasmodium vivax</it> vaccine based on recombinant chimpanzee adenovirus ChAd63 and MVA expressing TRAP

A novel <it>Plasmodium vivax</it> vaccine based on recombinant chimpanzee adenovirus ChAd63 and MVA expressing TRAP

Bibliographic Details
Main Authors:	Bauza Karolis, Billker Oliver, Hill Adrian VS, Reyes-Sandoval Arturo
Format:	Article
Language:	English
Published:	BMC 2012-10-01
Series:	Malaria Journal

Similar Items

Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal.
by: Victorine A Mensah, et al.
Published: (2016-01-01)

Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults.
by: Caroline Ogwang, et al.
Published: (2013-01-01)

Evaluation of Chimpanzee Adenovirus and MVA Expressing TRAP and CSP from <i>Plasmodium cynomolgi</i> to Prevent Malaria Relapse in Nonhuman Primates
by: Young Chan Kim, et al.
Published: (2020-07-01)

Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors.
by: Susanne H Sheehy, et al.
Published: (2012-01-01)

First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children.
by: Alfred B Tiono, et al.
Published: (2018-01-01)

Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing CS & ME-TRAP against controlled human malaria infection in malaria naïve individuals
by: Hodgson, S.H, et al.
Published: (2015)

Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial
by: Hans de Graaf, et al.
Published: (2021-07-01)

A phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates ChAd63 CS administered alone and with MVA CS.
by: Eoghan de Barra, et al.
Published: (2014-01-01)

Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposure.
by: Sumi Biswas, et al.
Published: (2014-01-01)

Chimpanzee Adenovirus Antibodies in Humans, Sub-Saharan Africa
by: Zhiquan Xiang, et al.
Published: (2006-10-01)

Development of an in vitro assay and demonstration of Plasmodium berghei liver-stage inhibition by TRAP-specific CD8+ T cells.
by: Rhea J Longley, et al.
Published: (2015-01-01)

Czy to ChAD? Dziesięć bardzo prostych pytań
by: Łukasz Święcicki
Published: (2018-03-01)

A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH.
by: Mohamed Osman, et al.
Published: (2017-05-01)

Plasmodium vivax Malaria
by: Dhanpat K. Kochar, et al.
Published: (2005-01-01)

Malaric relapses due to Plasmodium Vivax Reinfección engógena por Plasmodium vivax
by: Cecilia Giraldo, et al.
Published: (1991-01-01)

Antibody Responses Against Plasmodium vivax TRAP Recombinant and Synthetic Antigens in Naturally Exposed Individuals From the Brazilian Amazon
by: Ada da Silva Matos, et al.
Published: (2019-09-01)

Wild Chimpanzees Infected with 5 Plasmodium Species
by: Marco Kaiser, et al.
Published: (2010-12-01)

Plasmodium vivax Transmission in Africa.
by: Rosalind E Howes, et al.
Published: (2015-11-01)

<it>Plasmodium vivax</it>: who cares?
by: Barnwell John W, et al.
Published: (2008-12-01)

The anaemia of <it>Plasmodium vivax</it> malaria
by: Douglas Nicholas M, et al.
Published: (2012-04-01)

Plasmodium Vivax Associated Myocarditis
by: Ajinkya A Sonambekar, et al.
Published: (2014-04-01)

Plasmodium vivax transmission in Africa
by: Howes, Rosalind E., et al.
Published: (2015)

Seroprevalence of Neutralizing Antibodies against Human Adenovirus Type-5 and Chimpanzee Adenovirus Type-68 in Cancer Patients
by: Hua Zhao, et al.
Published: (2018-03-01)

Plasmodium vivax-like genome sequences shed new insights into Plasmodium vivax biology and evolution.
by: Aude Gilabert, et al.
Published: (2018-08-01)

Genetic diversity of <it>Plasmodium vivax</it> and <it>Plasmodium falciparum</it> in Honduras
by: Lopez Ana, et al.
Published: (2012-11-01)

Innate Immune Responses to Chimpanzee Adenovirus Vector 155 Vaccination in Mice and Monkeys
by: Catherine Collignon, et al.
Published: (2020-11-01)

Chimpanzee malaria parasites related to Plasmodium ovale in Africa.
by: Linda Duval, et al.
Published: (2009-01-01)

The Vivax Surveyor: Online mapping database for Plasmodium vivax clinical trials
by: R.J. Commons, et al.
Published: (2017-08-01)

The prevention and treatment of Plasmodium vivax malaria.
by: Cindy S Chu, et al.
Published: (2021-04-01)

Evaluation of Sensitivity of Plasmodium vivax to Chloroquine
by: Nateghpour M, et al.
Published: (2007-09-01)

Evaluation of Sensitivity of Plasmodium vivax to Chloroquine
by: Nateghpour M, et al.
Published: (2007-09-01)

Neutrophil paralysis in Plasmodium vivax malaria.
by: Fabiana Maria de Souza Leoratti, et al.
Published: (2012-01-01)

Concurrent Plasmodium vivax Malaria and Dengue
by: Stan Deresinski
Published: (2006-11-01)

Spatial Epidemiology of Plasmodium vivax, Afghanistan
by: Simon Brooker, et al.
Published: (2006-10-01)

Study of malignant syndromes of Plasmodium vivax
by: Niveditha Chalmeda, et al.
Published: (2018-01-01)

Suppression of erythropoiesis by <it>Plasmodium vivax</it> infection
by: Udomsangpetch Rachanee, et al.
Published: (2010-10-01)

Thrombocytopenia in Plasmodium vivax infected children
by: Bhushan Katira , Ira Shah
Published: (2006-09-01)

<it>Plasmodium vivax </it>trophozoites insensitive to chloroquine
by: Jaidee Anchalee, et al.
Published: (2008-05-01)

Changing profile of Plasmodium vivax malaria
by: M.E. Yeolekar, et al.
Published: (2014-04-01)

Plasmodium vivax malaria: Is it actually benign?
by: Harpal Singh, et al.
Published: (2011-06-01)